BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Harvard Business School
Chinese Patent Office
Express Scripts

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,006,528

« Back to Dashboard

Summary for Patent: 5,006,528

Title: Carbostyril derivatives
Abstract:A novel carbostyril derivative and salt thereof represented by the formula (1) ##STR1## (wherein R is a group of the formula ##STR2## ((wherein R.sup.1 is a C.sub.1- C.sub.3 alkoxy group)), a group of the formula ##STR3## ((wherein R.sup.2 and R .sup.3 are each, at the same time, a chlorine atom, a bromine atom; and R.sup.4 is a hydrogen atom or a chlorine atom)), 2-methyl-3-nitrophenyl group, 3,5-dichlorophenyl group, or a group of the formula ##STR4## ((wherein R.sup.5 is a chlorine atom or a bromine atom; and R.sup.6 is a methyl group)); the carbon-carbon bond between 3- and 4-position in the carbostyril skeleton is a single or double bond).
Inventor(s): Oshiro; Yasuo (Tokushima, JP), Sato; Seiji (Itano, JP), Kurahashi; Nobuyuki (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:07/424,719
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,006,528

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan63-276953Oct 31, 1988

International Patent Family for Patent: 5,006,528

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil1100204► Subscribe
China1028104► Subscribe
China1042537► Subscribe
Germany122004000043► Subscribe
Germany68925405► Subscribe
Denmark168485► Subscribe
Denmark539789► Subscribe
European Patent Office0367141► Subscribe300161Netherlands► Subscribe
European Patent Office0367141► SubscribeSPC/GB04/039United Kingdom► Subscribe
European Patent Office0367141► SubscribeC00367141/01Switzerland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus